fbpx

Male, 59 y/o

Patient internal ID: 337835457

ICD-10 code

C61 Malignant Neoplasm of Prostate

Diagnosis (incl metastases/stage) and year

September 2020
First diagnosed with Localized Prostate Adenocarcinoma 2013 (Gleason 3+4). In 2020 Advanced Prostate Carcinoma III st. cT3bN1M1a (Metastases to Infrarenal Lymph Nodes).

Previous treatment

Surgery (Lymphonodectomy), Hormone Therapy (Triptoreline and Bikalutamide), Radiation Therapy.

Prognosis and survival expectation

The median survival is around 42 months from diagnosis.

Treatment provided

Autologous DCV (8 doses) over a period of 2 months.
Additionally, the patient received Neoantigen Vaccines with Specific Peptides (10 doses).

Patient survival/condition and year

The patient is alive and has a stable disease with no needed treatment. It can be concluded that the addition of Immunotherapy, in combinations with Surgery, Hormone Therapy and Radiation Therapy, caused the regression of disease and disease control. The patient enjoys life and has only follow-up.

Date of Review

31/01/2024